CT-2103/Carboplatin for Patients With Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Carboplatin; Paclitaxel poliglumex
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors CTI BioPharma
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual completion date (1 Sep 2006) added as reported by ClinicalTrials.gov.
- 29 Sep 2005 New trial record.